• Asian Pacific Journal of Cancer Prevention
• /
• 제15권7호
• /
• pp.3267-3271
• /
• 2014

Background: Several studies have investigated the association between methionine synthase reductase (MTRR) A66G polymorphism and breast cancer risk, but controversial results were yielded. Therefore, we performed a meta-analysis to provide a more robust estimate of the effect of this polymorphism on susceptibility to breast cancer. Materials and Methods:Case-control studies investigating the relationship between MTRR A66G polymorphism and breast cancer risk were included by searching PubMed, EMBASE, China National Knowledge Infrastructure and Wanfang Database. Either fixed-effects or random-effects models were applied to calculate odds ratios(ORs) and 95% confidence intervals (CIs) by RevMan5.2 software. Results: A total of 9 studies bearing 7,097 cases and 7,710 controls were included in the meta-analysis. The results were that the combined ORs and 95%CIs of MTRR 66AG, GG, (AG+GG) genotypes were 0.98(0.91-1.05), 1.06(0.97-1.16) and 1.02(0.94-1.10), respectively with p=0.52, 0.19 and 0.65. We also performed subgroup analysis by specific ethnicity. The results of the combined analysis of MTRR 66AG, GG, (AG+GG) genotypes and breast cancer in Asian descent were Z=0.50, 0.53 and 0.21, with p all>0.05; for breast cancer in Caucasian descent, the results were Z=1.14, 1.65 and 0.43, with p all>0.05. Conclusions: Our findings suggested that MTRR A66G polymorphism was not associated with breast cancer susceptibility.

• Journal of Genetic Medicine
• /
• 제5권2호
• /
• pp.119-124
• /
• 2008

목 적: 다운증후군을 비롯한 염색체의 수적이상은 태아의 유산이나 정신박약의 가장 큰 요인으로 알려져 있다. 이에 본 연구에서는 엽산 대사에 관련된 효소의 다형성(MTHFR C677T, MTRR A66G)을 조사하여 태아의 염색체 수적이상과 유전적인 연관성을 알아보고자 한다. 대상 및 방법: 염색체 수적이상이 확인된 태아를 임신한 37명의 산모와 유산이나 비정상적인 임신을 한 경험이 없고 2명 이상의 건강한 아이를 출산한 78명의 여성을 정상군으로 하여 혈액으로부터 DNA를 추출하고 PCR-RFLP를 이용하여 각 지역의 다형성 여부를 확인하였다. 결 과: MTHFR C677T 유전자형은 CC, CT, TT에 대해 각각 30.7%, 48.7%, 20.6%였으며, 환자군에서 각각 37.8%, 48.6%, 13.5% 였다. 정상군과 환자군 사이 모든 조합에서 유의한 차이를 보이지 않았다. 대립유전자의 비율 역시 대조군과 환자군에서 각각 44.9%, 37.8%였으며, 통계적 유의한 차이는 없었다. MTRR A66G 유전자형은 대조군에서 AA, AG, GG에 대해 각각 50.0%, 46.1%, 3.9%였으며, 환자군에서는 각각 13.5%, 81.1%, 5.4%였다. MTRR의 정상 유전자형인 AA와 이형접합성 변이형인 AG 유전자형을 비교하였을 때 유의한 차이를 보였으며(OR: 6.5, 95% CI: 2.3-18.6, P<0.05), 정상이 아닌 모든 다른 유전자형(AG/GG)과 비교하였을 때에도 역시 유의한 차이를 보였다(OR: 6.4, 95% CI: 2.3-18.1, P<0.05). 결 론: 본 연구에서는 MTHFR 677번째 염기의 다형성은 염색체 비분리로 인한 태아 염색체의 수적이상과 연관성이 없는 것으로 확인하였으나, MTRR 66부위의 경우 염기의 다형성이 태아 염색체의 수적이상을 유발하는 유전적 요소로서의 가능성을 제시하고 있다.

• Genomics & Informatics
• /
• 제10권3호
• /
• pp.184-193
• /
• 2012

Gastric cancer is ranked as the most common cancer in Koreans. A recent molecular biological study about the folate pathway gene revealed the correlation with a couple of cancer types. In the folate pathway, several genes are involved, including methylenetetrahydrofolate reductase (MTHFR), methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR), and methyltetrahydrofolate-homocysteine methyltransferase (MTR). The MTHFR gene has been reported several times for the correlation with gastric cancer risk. However, the association of the MTRR or MTR gene has not been reported to date. In this study, we investigated the association between the single nucleotide polymorphisms (SNPs) of the MTHFR, MTRR, and MTR genes and the risk of gastric cancer in Koreans. To identify the genetic association with gastric cancer, we selected 17 SNPs sites in folate pathway-associated genes of MTHFR, MTR, and MTRR and tested in 1,261 gastric cancer patients and 375 healthy controls. By genotype analysis, estimating odds ratios and 95% confidence intervals (CI), rs1801394 in the MTRR gene showed increased risk for gastric cacner, with statistical significance both in the codominant model (odds ratio [OR], 1.39; 95% CI, 1.04 to 1.85) and dominant model (OR, 1.34; 95% CI, 1.02 to 1.75). Especially, in the obese group (body mass index ${\geq}25kg/m^2$), the codominant (OR, 9.08; 95% CI, 1.01 to 94.59) and recessive model (OR, 3.72; 95% CI, 0.92 to 16.59) showed dramatically increased risk (p < 0.05). In conclusion, rs1801394 in the MTRR gene is associated with gastric cancer risk, and its functional significance need to be validated.